Related Experiment Video

Updated: May 16, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences

Jennifer Ng1, Jennifer Wu

  • 1Department of Medicine, New York University Langone Medical Center, New York, United State.

Hepatitis Monthly
|December 13, 2012
PubMed

Insights

Hepatitis B (HBV) and Hepatitis C (HCV) cause liver cancer (HCC) differently. Understanding these distinct viral risk factors and clinical presentations is key to developing tailored treatments for HBV- and HCV-related HCC.

Area of Science:

  • Hepatology
  • Viral Oncology
  • Cancer Etiology

Background:

  • Hepatocellular carcinoma (HCC) is a major outcome of Hepatitis B (HBV) and Hepatitis C (HCV) infections.
  • While sharing common host/environmental risk factors, HBV and HCV exhibit distinct viral risk factors and etiological mechanisms for HCC.
  • Independent study of HBV- and HCV-related HCC is crucial due to their unique characteristics.

Purpose of the Study:

  • To highlight the distinct viral risk factors and etiological mechanisms of HBV- and HCV-related HCC.
  • To compare the clinical presentations and treatment responses of HCC based on HBV or HCV etiology.
  • To underscore the need for tailored treatment strategies for each type of viral hepatitis-induced HCC.

Main Methods:

  • Analysis of viral factors (HBV DNA levels, HBeAg, viral mutations) predisposing to HCC in HBV infection.
  • Assessment of viremia as a risk factor for HCC in HCV infection.
  • Comparison of carcinogenesis mechanisms, including viral integration in HBV.
  • Evaluation of differing transmission routes (vertical for HBV, horizontal for HCV).

Main Results:

  • HBV and HCV differ in transmission routes, leading to distinct clinical presentations.
  • HBV-related HCC patients are often younger with larger tumors, while HCV-related HCC patients present with poorer liver function.
  • HBV-related HCC shows faster progression post-sorafenib treatment compared to HCV-related HCC.

Conclusions:

  • Significant differences exist in the clinical presentation and treatment response between HBV- and HCV-related HCC.
  • Tailored treatment strategies addressing the specific etiology of HCC are needed.
  • Further research into these differences will improve patient outcomes for both HBV- and HCV-related HCC.
Abstract

Keywords:
Hepatitis B VirusHepatitis CHepatocellular Carcinoma

More Related Videos

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...